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A B S T R A C T   
Background: Aortic dissection is a life-threatening complication of bicuspid aortic valve (BAV)-associated aort-
opathy. In these populations, whilst prophylactic replacement of proximal thoracic aortic aneurysms (TAAs) is 
generally recommended at threshold diameters ≥5.5 cm, dissection may occur in smaller aortas. An alternative 
size-based parameter, the cross-sectional aortic area/patient height ratio (indexed aortic area, IAA), correlates 
with increased dissection risk at abnormal values > 10 cm2/m. We sought to assess the utility of the IAA in 
identifying at-risk BAV-associated TAAs with abnormal IAA, albeit with sub-threshold aortic diameter. 
Materials and methods: We retrospectively identified 69 patients with BAV-associated TAAs who underwent 
surgical repair between 2010 and 2016. Aortic diameter was measured on pre-operative imaging, and IAA 
calculated, at the mid-sinus of Valsalva, sino-tubular junction and mid-ascending aorta for each patient. We 
determined proportions of aneurysms with IAA >10 cm2/m, median IAAs corresponding to aortic diameters 
<4.0 cm, 4.0–4.5 cm, 4.5–5.0 cm, 5.0–5.5 cm and >5.5 cm, and median aortic diameters corresponding to an 
abnormal IAA. 
Results: 50.9%, 12.5% and 64.6% of aneurysms at the sinus of Valsalva, sino-tubular junction and mid-ascending 
aorta, respectively, had an abnormal IAA. 51.9% and 88.9% of patients with aortic diameter 4.5–5.0 cm and 
5.0–5.5 cm, respectively, had an abnormal IAA. In aneurysms with abnormal IAA involving the sinus of Valsalva, 
sino-tubular junction, and mid-ascending aorta, median aortic diameters were 4.98 cm, 5.04 cm and 5.11 cm, 
respectively. Overall, 57/72 (79.2%) at-risk aneurysms with IAA >10 cm2/m had diameters smaller than the 5.5 
cm guideline cut-off for surgical intervention. 
Conclusion: Significant proportions of BAV-associated TAAs are at increased risk of aortic dissection attending an 
IAA >10 cm2/m, whilst not fulfilling the size criteria indicating aortic surgery in contemporary guidelines. 
Further analysis of IAA in larger BAV cohorts is necessary to clarify its role in patient selection and optimal 
timing for prophylactic aortic replacement.   
1. Introduction 
Mounting evidence suggests acute dissection or rupture may occur 
within smaller aortas before achieving a 4.5–5.5 cm diameter, which 
would normally indicate surgical intervention in both tri-leaflet and 
bicuspid aortic valve (BAV) populations without inherited aortopathy or 
additional risk factors [1–3]. These criteria are unchanged in the 
updated 2020 American College of Cardiology/American Heart 
Association guidelines for the management of valvular heart disease [4]. 
However, in the International Registry of Acute Aortic Dissection series, 
59% and 40% of patients presenting with acute type A dissection had 
ascending aortic diameter <5.5 cm and <5.0 cm, respectively [5]. 
Furthermore, 15% of patients with Marfan-related aortopathy undergo 
aortic dissection at diameters <5.0 cm [6]. Elastic tissue loss from the 
aortic media in BAV-associated aneurysms also renders them susceptible 
to dissection at risks comparable to those of a Marfan population [7,8]. It 
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is also well-recognised that aortic aneurysms demonstrate accelerated 
expansion in the context of a BAV compared to a tri-leaflet valve, irre-
spective of valvular dysfunction [9]. 
A “one size fits all” approach to patient selection for prophylactic 
aortic surgery, heavily reliant on absolute diameter as a static deter-
minant of aortic dimension, may thus be inappropriate, and unknow-
ingly expose patients under routine surveillance to potentially life- 
threatening aortic complications. Pure diameter measurements fail to 
account for the irregular, elliptical shape of the thoracic aorta that is 
often encountered with BAVs [10]. 
An alternative size-based parameter, the cross-sectional aortic area/ 
patient height ratio (indexed aortic area, IAA), has previously been 
validated in the stratification of mortality risk in patients with both 
bicuspid and tri-leaflet aortic valves and concomitant aortopathy. An 
abnormal ratio exceeding 10 cm2/m denotes an augmented dissection/ 
rupture risk [6,8,10–12]. This cut-off value has been incorporated into 
the most recent iterations of the surgical guidelines as an indication for 
elective aortic replacement in patients with BAV aortopathy [3]. 
Our group previously correlated IAAs and aortic diameter in patients 
with thoracic aortic aneurysms between the aortic root and mid- 
ascending aorta [13]. We found that 69.5% of these aneurysms with 
abnormal IAAs, the majority associated with tri-leaflet aortic valves, 
would likely be denied operative intervention on account of their 
sub-threshold aortic diameters. In extension, the present study aimed to 
characterise therelationship between observed IAAs and aortic diameter 
in patients with BAV aortopathy to assess whether sub-threshold TAAs 
still harbour significant risk from an IAA >10 cm2/m. 
2. Material and methods 
2.1. Definitions 
An aortic segment with diameter ≥4 cm, as measured on multi- 
planar contrast-enhanced computed tomography (CT) or magnetic 
resonance imaging (MRI), was considered aneurysmal. BAVs were 
identified on pre-operative trans-thoracic echocardiography and 
confirmed during surgery. 
2.2. Patient population and study design 
We performed a retrospective observational study including all 
consecutive adult patients undergoing first-time surgery for a BAV- 
related aneurysm involving the aortic root and/or ascending aorta, be-
tween 2010 and 2016 at our institution. Patient selection for surgery was 
primarily based on, but not limited to, the aforementioned aortic 
diameter cut-offs recommended in surgical guidelines, in addition to 
observed IAAs, cardiovascular risk factors and family and genetic his-
tory, and with consensus from an experienced aortic multi-disciplinary 
panel. This study has been reported in line with the STROCSS criteria 
[14]. The research registration unique identifying number (UIN) is 
NCT04756778, available at http://clinicaltrials.gov. 
2.3. Data collection 
Prospectively collected data on patient height at the time of surgery 
and other variables was obtained from our institutional computer 
database. The local ethics committee waivered the requirement for 
ethical approval for this retrospective study. 
2.4. Imaging review 
The multi-planar CT and/or MRI scan closest to the time of surgery 
was retrospectively reviewed for each patient. Maximum aortic di-
ameters were measured using the outer edge-to-outer edge calliper 
technique in a plane perpendicular to blood flow at three aortic loca-
tions: the mid-point of the sinuses of Valsalva, the sino-tubular junction 
and the mid-ascending aorta at the level of the pulmonary artery 
bifurcation. The largest aortic diameter obtained from coronal and 
sagittal views was utilised for analysis. All imaging studies were 
reviewed by a single clinician with cross-checking of a randomly 
selected 10% sample by two experienced cardiovascular radiologists to 
ensure consensus in measurement technique and reproducibility. 
2.5. Outcome measures 
Median aortic diameters for all aneurysms (diameter ≥4 cm) 
occurring at each aortic location were calculated. Cross-sectional aortic 
area was calculated using the formula π x r2, where r represents the 
aortic radius (cm). This value was divided by patient height (m) to 
determine the cross-sectional aortic area/patient height ratio (cm2/m) 
(indexed aortic area, IAA). After identifying patients with an aneurysm 
at a given aortic location, we proceeded to calculate the median IAA, 
and proportion of at-risk patients with IAA >10 cm2/m, for the group of 
aneurysms at each aortic location. Next, aortic segments were assigned 
according to diameter to different sub-groups (<4.0 cm, 4.0–4.5 cm, 
4.5–5.0 cm, 5.0–5.5 cm or >5.5 cm), for each of which the median IAA 
was calculated. Finally, the median aortic diameter corresponding to 
aneurysms with IAA >10 cm2/m was calculated at each aortic location. 
2.6. Statistical analysis 
Statistics are presented as percentages for categorical variables, and 
medians and ranges for continuous variables. 
3. Results 
3.1. Patient population 
69 patients with BAVs undergoing surgery for thoracic aortic aneu-
rysms between 2010 and 2016 at our institution were eligible for 
analysis. Pre-operative patient characteristics are shown in Table 1. Out 
of these 69 patients, aneurysms involved the mid-sinus of Valsalva in 53 
(76.8%), the sino-tubular junction in 24 (34.8%) and the mid-ascending 
aorta in 65 (94.2%). 47/69 patients (68.1%) had a regurgitant BAV and 
2/69 (2.9%) had Marfan’s syndrome. Table 2 shows the distribution of 
aortic procedures performed. 
3.2. Median aortic diameter 
We identified aneurysms with diameter ≥4 cm and calculated the 
median diameter for these aneurysms at each aortic location, as shown 
in Table 3. Notably, median diameters for BAV-related TAAs were all 
<5.0 cm. 
3.3. Median indexed aortic areas and indexed aortic areas >10 cm2/m 
Table 4 shows the median IAAs, and proportions of BAV-related 
TAAs with IAA >10 cm2/m, between the aortic root and mid- 
ascending aorta. Median IAAs exceeded the 10 cm2/m cut-off, indi-
cating an elevated risk of aortic dissection/rupture, at both the mid- 
sinus and mid-ascending aorta locations at 10.1 cm2/m and 11.0 cm2/ 
m, where 27/53 (50.9%) and 42/65 (64.6%) patients, respectively, had 
an abnormal IAA. Only 3/24 (12.5%) patients with aneurysms at the 
sino-tubular junction had an abnormal IAA, although the median IAA of 
8.52 cm2/m here approached the 10 cm2/m cut-off value. 
Importantly, out of a total of 142 aneurysmal aortic segments in this 
group of 69 patients with a BAV, 72 (50.7%) were associated with an 
abnormal IAA. 
3.4. Median indexed aortic areas corresponding to aortic diameter 
Fig. 1 demonstrates median IAAs corresponding to aortic diameters 
M. Acharya et al.                                                                                                                                                                                                                               
Annals of Medicine and Surgery 65 (2021) 102342
3
<4.0 cm, 4.0–4.5 cm, 4.5–5.0 cm, 5.0–5.5 cm and >5.5 cm at mid-sinus, 
sino-tubular junction and mid-ascending aortic locations. Median IAAs 
increase proportionally with enlarging aortic diameter. Abnormal me-
dian IAAs surpassing the 10 cm2/m cut-off value, indicated by the 
horizontal red line, first emerge at diameters of 4.5–5.0 cm with values 
of 10.2 cm2/m and 10.1 cm2/m at the mid-sinus and mid-ascending 
aortic locations, respectively. Median IAAs within the 5.0–5.5 cm 
diameter range clearly surpassed the abnormal 10 cm2/m cut-off value, 
regardless of the aortic segment involved. 
Table 5 shows the proportions of aneurysms with IAA >10 cm2/m for 
each aortic diameter range. There were no aneurysms with abnormal 
IAA corresponding to aortic diameter <4.5 cm. However, 28/54 
(51.9%) aneurysms with aortic diameter 4.5–5.0 cm had an abnormal 
IAA, rising to 24/27 (88.9%) at 5.0–5.5 cm and 15/15 (100%) at 
diameter >5.5 cm. Therefore, out of a total 81 intermediate-sized an-
eurysms between 4.5 and 5.5 cm in diameter, a significant 52 (64.2%) 
had an abnormal IAA. 
3.5. Relationship between indexed aortic area and aortic diameter 
Aneurysms with IAA >10 cm2/m were grouped according to the 
aortic location to determine their median diameter and the proportions 
of individual aneurysms with diameter <5.5 cm. As shown in Table 6, 
median aortic diameter was <5.5 cm across all aortic locations, being 
4.98 cm at the mid-sinus of Valsalva, 5.04 cm at the sino-tubular junc-
tion and 5.11 cm at the mid-ascending aorta. 22/27 (81.5%), 3/3 
(100%) and 32/42 (68.6%) of aneurysms with an abnormal IAA 
involving the mid-sinus of Valsalva, sino-tubular mid-ascending aorta, 
respectively, concurrently had a diameter <5.5 cm. 
Considering the entire group of 72 BAV-related aneurysms with an 
IAA >10 cm2/m, a significant 57 (79.2%) had an aortic diameter <5.5 
cm. In the absence of any valvular indication for surgery, they would not 
fulfil the size criteria indicating aortic surgery recommended in current 
guidelines, albeit being subject to an elevated risk of aortic complica-
tions. Under strict interpretation of these recommendations, surgical 
intervention would only be applicable in 15/72 aortic segments (20.8%) 
in this BAV population with both abnormal IAA and aortic diameter 
>5.5 cm. 
4. Discussion 
This is the first study to evaluate the relationship between aortic 
diameter and cross-sectional aortic area/patient height ratio (indexed 
aortic area, IAA) exclusively in patients with BAV aortopathy. We 
employed an abnormal IAA >10 cm2/m as a size-based determinant of 
increased risk to identify those aneurysms susceptible to aortic dissec-
tion/rupture, especially those with smaller aortic diameters than are 
recommended for surgical resection. Importantly, we did not seek to 
quantify the exact risks associated with an IAA >10 cm2/m, compare 
outcomes between surgical intervention and medical management of 
BAV aortopathy at any particular diameter interval, and neither did we 
aim to assess the incidence of aortic adverse events, namely dissection, 
rupture and re-intervention, in our study population. 
Our results confirm that (i) IAA can be utilised effectively to identify 
those aneurysms at increased risk of dissection/rupture attributed to 
IAA >10 cm2/m, (ii) large proportions of patients at sub-threshold aortic 
diameters of 4.5–5.0 cm possess abnormal IAAs and (iii) large pro-
portions of BAV-related proximal aortic aneurysms remain are at 
increased risk of these adverse aortic events but may not be selected for 
Table 1 
Pre-operative patient characteristics.  
Characteristic Value 
Age (years) 61 (52–68) 
Male 59 (85.5) 
BMI 27 (24–30) 
Logistic EuroSCORE 4.65 (2.23–6.37) 
NYHA class 
I 22 (31.9) 
II 39 (56.5) 
III 8 (11.6) 
Hypertension 34 (49.3) 
Hypercholesterolaemia 22 (31.9) 
Smoking 33 (47.8) 
Pulmonary disease 4 (5.8) 
CKD stage 
1 31 (44.9) 
2 34 (49.3) 
3 2 (2.9) 
4 1 (1.4) 
5 1 (1.4) 
Pre-operative dialysis 1 (1.4) 
TIA/CVA 4 (5.8) 
Previous MI 7 (10.1) 
Peripheral vascular disease 0 (0.0) 
LV function 
Good 60 (87.0) 
Moderate 7 (10.1) 
Poor 2 (2.9) 
RV function 
Good 67 (97.1) 
Moderate 2 (2.9) 
Poor 0 (0.0) 
Marfan syndrome 2 (2.9) 
Other connective tissue disease 0 (0.0) 
Aortic regurgitation 47 (68.1) 
Values are n (%) or median (inter-quartile range). 
BMI, body mass index; CKD, chronic kidney disease; CVA, cerebrovascular 
accident; EuroSCORE, European System for Cardiac Operative Risk Eval-
uation; LV, left ventricle; MI, myocardial infarction; NYHA, New York 
Heart Association; RV, right ventricle; TIA, transient ischemic attack. 
Table 2 
Distribution of aortic procedures performed.  
Procedure Value 
Aortic root replacement 35 (50.7) 
Aortic root replacement + CABG 6 (8.70) 
Ascending aortic replacement + AVR 20 (29.0) 
Ascending aortic replacement + AVR + CABG 6 (8.70) 
Ascending aortic replacement + arch replacement + AVR 1 (1.45) 
Ascending aortic replacement + arch replacement 1 (1.45) 
Values are n (%). 
AVR, aortic valve replacement; CABG, coronary artery bypass graft. 
Table 3 
Median aortic diameter in BAV-related thoracic aortic aneurysms according 
to aneurysm location.  
Aneurysm location Aortic diameter (cm) 
Mid-sinus (n = 53) 4.75 (4.05–5.86) 
Sino-tubular junction (n = 24) 4.43 (4.00–5.10) 
Mid-ascending (n = 65) 4.90 (4.45–9.12) 
Values are median (range). 
Table 4 
Median indexed aortic areas (cm2/m) and proportions of aortic aneurysms with 
indexed aortic area >10 cm2/m according to aneurysm location in patients with 
BAV-related thoracic aortic aneurysms.  
Aneurysm 
location 
Median indexed aortic area 
in aneurysms 
cm2/m 
Indexed aortic area >10 cm2/ 
m in aneurysms 
N (%) 
Mid-sinus 10.1 (7.25–18.3) 27/53 (50.9) 
Sino-tubular 
junction 
8.52 (5.38–11.9) 3/24 (12.5) 
Mid-ascending 11.0 (6.97–40.8) 42/65 (64.6) 
Values are median (range) or n (%). 
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surgery owing to diameter <5.5 cm. 
Studies analysing indexed measurements of aortic size in BAV pa-
tients as pertains to the risk of aortic adverse events and selection for 
preventative aortic surgery are limited in literature. Only two relevant 
papers were retrieved from a search on the PubMed database using the 
terms “cross-sectional aortic area AND bicuspid”. Svensson and col-
leagues operated on 40 patients with BAV-associated acute and chronic 
aortic dissections and reported that 35% had aortic diameters <5.5 cm, 
with a mean IAA of 18.34 ± 8.88 cm2/m [8]. Masri and colleagues 
evaluated IAA in asymptomatic patients with BAV-related TAAs, 
observing that the IAA was abnormal in 33% of 969 patients with a 
dilated proximal aorta in conjunction with a BAV [11]. Furthermore, 
they identified 64% of 405 patients, and 43% of 256 patients with a 
4.5–5.5 cm “intermediate-sized” ascending aorta or aortic root, respec-
tively, had an IAA exceeding the 10 cm2/m cut-off [11]. 
BAV represents the most common congenital heart defect prevalent 
in approximately 1–2% of adults [15,16]. The potential adverse 
sequelae, including aortic valve dysfunction, endocarditis, aortic 
coarctation, aneurysm formation and acute dissection or rupture, render 
bicuspid aortic valvulopathy accountable for more deaths than all other 
congenital heart lesions combined [17]. Proximal aortic dilatation af-
fects around 40–60% of patients with BAV aortopathy irrespective of 
valve dysfunction [18,19], and both aortic expansion and valvular ste-
nosis progress faster in association with a BAV [20–22]. Aortic dissec-
tion occurs at an earlier age in patients with BAV, in whom the risks of 
aortic dissection and rupture remain 6- to 9-fold greater than in the 
general population [23,24]. 
Recently there has been greater emphasis on elucidating the natural 
history of BAV disease to garner support for its more aggressive treat-
ment on account of its potentially life-threatening complications. Yet 
despite advancements in the understanding of the pathophysiological 
mechanisms and genetic basis of BAV aortopathy in recent years, in 
addition to the implications of aortic dimensions, valve phenotype and 
ascending aortic morphology [13,25–30], there is conflicting evidence 
on the optimal timepoint for surgical intervention on proximal TAAs in 
patients with BAV. In the absence of a valvular indication and coexisting 
risk factors, guidelines justify surgery in this group at aortic diameters 
≥5.5 cm [1–3]. However, patients undergoing isolated BAV replacement 
with accompanying ascending aortic diameter <5.0 cm are nevertheless 
significantly vulnerable to future complications in the non-intervened 
aorta [31,32]. 
In the present study, we demonstrate that 57/72 (79.2%) BAV- 
associated aneurysms with an abnormal IAA might not be eligible for 
aortic repair despite their greater susceptibility to aortic dissection, 
since they fall short of the diameter thresholds at which aneurysm sur-
gery is proposed in current management guidelines. Abnormal IAAs first 
become apparent in BAV-related TAAs at aortic diameters of 4.5–5.0 cm, 
where over half of aneurysms had an IAA >10 cm2/m. By the time the 
aorta has acquired a 5.0–5.5 cm diameter, IAAs are abnormal in over 
88% of patients with a BAV. This is in concurrence with previous work 
from our group showing that 49.1% and 98.5% of dilated thoracic aortas 
measuring 4.5–5.0 cm and 5.0–5.5 cm, respectively, possessed abnormal 
IAAs in a mixed, predominantly tri-leaflet, aortic valve population [13]. 
Median aortic diameters for aneurysms at the mid-sinus, sino-tubular 
junction and mid-ascending aortic locations were all smaller than the 
5.5 cm threshold advocated for aortic replacement, and in fact, fewer 
than 5 cm. Despite this, median IAAs were 10.1 cm2/m at the mid-sinus, 
where IAA in over 50% of aneurysms surpassed the 10 cm2/m limit 
indicative of increased aortic complication risks, and 11.0 cm2/m at the 
mid-ascending aorta, where almost 65% of patients had an increased 
IAA. At the sino-tubular junction, median IAAs in BAV-related aneu-
rysms approached an abnormal value at 8.52 cm2/m, but only 12.5% of 
individual aneurysms at this location had an elevated IAA. 
Whilst contemporary guidelines endorse replacement of the aneu-
rysmal thoracic aorta in the presence of a functional BAV once a critical 
diameter of 5.5 cm is reached [1–3], it is evident from the present study 
that IAAs at this aortic diameter are highly abnormal, and it may 
therefore be inappropriate to delay surgery until the aorta has attained 
this size. Many patients could experience a lethal aortic event once their 
IAA exceeds 10 cm2/m, but before even reaching a 5.5 cm aortic 
Fig. 1. Median indexed aortic areas corresponding to aortic diameter in BAV-related thoracic aortic aneurysms (red line denotes indexed aortic area cut-off value at 
10 cm2/m). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
Table 5 
Proportions of BAV-related thoracic aortic aneurysms with indexed aortic area 
>10 cm2/m according to aortic diameter.  
Aortic diameter (cm) N (%) 
<4.0 0/64 (0.0) 
4.0–4.5 0/43 (0.0) 
4.5–5.0 28/54 (51.9) 
5.0–5.5 24/27 (88.9) 
>5.5 15/15 (100)  
Table 6 
Relationship between indexed aortic area ranges and median aortic diameters in 
BAV-related thoracic aortic aneurysms.   
Aneurysm location 
Mid-sinus 
N = 27 
Sino-tubular 
junction 
N = 3 
Mid-ascending 
N = 42 




5.04 (5.03–5.10) 5.11 
(4.63–9.12) 
Aneurysms with diameter 
<5.5 cm 
N (%) 
22/27 (81.5) 3/3 (100) 32/42 (68.8) 
Values are median (range) or n (%). 
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diameter. Indeed, at diameters >5.5 cm, all patients with BAV in our 
series had a markedly abnormal IAA, ranging from 14.3 cm2/m at the 
mid-sinus to 40.8 cm2/m at the mid-ascending aorta. 
Our important findings suggest that intervening on patients with 
bicuspid valve aortopathy at the present 5.5 cm diameter cut-off, in the 
absence of additional risk factors, may not be sufficient to prevent the 
onset of potentially disastrous aortic events. The occurrence of abnormal 
IAA even at diameter ranges of 4.5–5.0 cm nevertheless implies signif-
icant aortic risk. Further work is necessary to ascertain whether IAA may 
be a better size-based determinant for surgery than absolute diameter in 
BAV populations, and the optimal size interval at which aortic 
replacement should be performed in this high-risk category. Funda-
mental to patient selection for aortic surgery is careful consideration of 
the potential hazards and intended benefits of the planned procedure on 
an individual patient basis. Whilst dedicated aortic centres demonstrate 
excellent and reproducible long-term results, the operative risks of 
stroke, endocarditis and graft infection must be judiciously balanced 
against the accruing annual risks of dissection/rupture in those under-
going surveillance without definitive surgical treatment. 
The main strength of this study is that it represents the first analysis 
to correlate indexed aortic area, as a validated and alternative indicator 
of aortic dimensions, with absolute aortic diameter in proximal thoracic 
aortic aneurysms associated exclusively with a BAV. In this special 
population, we identifiy susceptible aneurysms which might otherwise 
not be deemed to be at such a significant risk of aortic complications to 
warrant intervention, on the basis of their sub-threshold aortic diameter. 
The retrospective, observational nature of this study implies poten-
tial for referral and selection bias. Whilst our BAV study population was 
relatively small, it is plausible that the key findings obtained would not 
be significantly altered by simply increasing the pool of patients ana-
lysed. Utilising the formula π x r2 for aortic area calculations may 
incorrectly assume a circular cross-section to the aorta, whereas a 
planimetry technique may be more precise. Furthermore, by design, it is 
beyond the scope of this study to recommend a more conservative 
diameter threshold for the surgical resection of BAV-related aneurysms 
than that documented in current guidelines, since this would mandate 
prospective analyses incorporating outcome data from extended longi-
tudinal follow-up. 
5. Conclusion 
Significant proportions of patients with a BAV and proximal aortic 
aneurysms have abnormal IAAs >10 cm2/m, indicating their increased 
risk of dissection or rupture, associated with sub-threshold aortic di-
ameters that do not satisfy the size criteria justifying surgical interven-
tion proposed in international guidelines. The role of the IAA parameter 
requires further assessment to clarify whether patients with BAV-related 
aortopathy warrant more proactive surgery at smaller aortic diameters 
than are currently recommended. 
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